Treating latent tuberculosis with rifampin: is it the cheaper option?
Publication
, Journal Article
Stout, JE; Holland, DP
Published in: Thorax
July 2010
Duke Scholars
Published In
Thorax
DOI
EISSN
1468-3296
Publication Date
July 2010
Volume
65
Issue
7
Start / End Page
572 / 573
Location
England
Related Subject Headings
- Rifampin
- Respiratory System
- Latent Tuberculosis
- Humans
- Health Care Costs
- Antibiotics, Antitubercular
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Stout, J. E., & Holland, D. P. (2010). Treating latent tuberculosis with rifampin: is it the cheaper option? Thorax, 65(7), 572–573. https://doi.org/10.1136/thx.2010.138685
Stout, Jason E., and David P. Holland. “Treating latent tuberculosis with rifampin: is it the cheaper option?” Thorax 65, no. 7 (July 2010): 572–73. https://doi.org/10.1136/thx.2010.138685.
Stout JE, Holland DP. Treating latent tuberculosis with rifampin: is it the cheaper option? Thorax. 2010 Jul;65(7):572–3.
Stout, Jason E., and David P. Holland. “Treating latent tuberculosis with rifampin: is it the cheaper option?” Thorax, vol. 65, no. 7, July 2010, pp. 572–73. Pubmed, doi:10.1136/thx.2010.138685.
Stout JE, Holland DP. Treating latent tuberculosis with rifampin: is it the cheaper option? Thorax. 2010 Jul;65(7):572–573.
Published In
Thorax
DOI
EISSN
1468-3296
Publication Date
July 2010
Volume
65
Issue
7
Start / End Page
572 / 573
Location
England
Related Subject Headings
- Rifampin
- Respiratory System
- Latent Tuberculosis
- Humans
- Health Care Costs
- Antibiotics, Antitubercular
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences